Sponsors (7)
Creates statutory definitions and labeling rules for cell-cultivated and plant-based protein products, makes cell-cultivated meat/poultry subject to USDA inspection, and requires agencies to set common standards of identity.
Official title: Amend the Federal Meat Inspection Act and the Poultry Products Inspection Act to ensure that consumers can make informed decisions in choosing between meat and poultry products and cell-cultivated protein products, and for other purposes.
Introduced April 30, 2026 by John Peter Ricketts · Last progress April 30, 2026
The bill increases consumer safety and transparency for cell‑cultivated and plant‑based products by clarifying USDA/FDA roles, inspections, standards, and labeling — at the cost of higher compliance burdens, potential short‑term price increases, slower market entry, and administrative strain that disproportionately affect small producers.
Consumers and public health systems get clearer, unified federal safety oversight of cell‑cultivated protein products as USDA and FDA roles, inspections, and FDA premarket consultations are clarified.
Consumers gain clearer labeling: cell‑cultivated products must be identified as "cell‑cultivated" and plant‑based alternatives labeled as such, reducing confusion about product origin.
Producers (including small businesses) receive greater regulatory clarity and predictable rules—through defined USDA/FDA responsibilities and development of standards—which can speed commercialization and attract investment.
Small manufacturers and startups face higher compliance costs from new premarket consultations, labeling requirements, inspections, and facility standards.
Tighter federal oversight and added inspection steps could slow market entry and raise consumer prices in the short term.
Prominent disclaimers that products are not "naturally produced" meat may stigmatize cell‑cultivated products, reducing consumer demand and harming producers' revenues.
Based on analysis of 3 sections of legislative text.
Requires USDA and HHS/FDA to revise their 2019 interagency agreement to divide regulatory duties for cell-cultivated protein products, makes cell-cultivated meat and poultry subject to USDA inspection, and creates new, mandatory labeling and definitions for cell-cultivated and plant-based alternative protein products. Agencies must also develop common standards of identity and additional safety requirements for cell banks and culturing facilities within set time frames. The law directs USDA to implement inspection and statutory coverage for cell-cultivated meat and poultry, assigns FDA responsibility for premarket consultation and certain manufacturing and biological-safety oversight, and mandates prominent labeling that discloses whether products are cell-cultivated or plant-based alternatives and that they are not derived from naturally produced meat or poultry.